BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23547048)

  • 21. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in cortical bone and their relationship to biochemical variables in Black and White children in the early stages of puberty.
    Warden SJ; Hill KM; Ferira AJ; Laing EM; Martin BR; Hausman DB; Weaver CM; Peacock M; Lewis RD
    Osteoporos Int; 2013 Jun; 24(6):1869-79. PubMed ID: 23093348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
    Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
    Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
    Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism.
    Heubi JE; Hollis BW; Specker B; Tsang RC
    Hepatology; 1989 Feb; 9(2):258-64. PubMed ID: 2783577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.
    Metzger M; Houillier P; Gauci C; Haymann JP; Flamant M; Thervet E; Boffa JJ; Vrtovsnik F; Froissart M; Stengel B; Ureña-Torres P;
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2922-8. PubMed ID: 23633202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
    Fidan N; Inci A; Coban M; Ulman C; Kursat S
    J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
    Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease.
    Laster M; Denburg M; Okuda Y; Kumar J; Furth S; Warady B; Kalantar-Zadeh K; Norris K; Salusky IB
    J Bone Miner Res; 2021 Feb; 36(2):298-304. PubMed ID: 32960469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection.
    Haderslev KV; Jeppesen PB; Sorensen HA; Mortensen PB; Staun M
    Gut; 2003 May; 52(5):653-8. PubMed ID: 12692048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.
    Greer RM; Buntain HM; Potter JM; Wainwright CE; Wong JC; O'Rourke PK; Francis PW; Bell SC; Batch JA
    Osteoporos Int; 2003 Jun; 14(5):404-11. PubMed ID: 12730764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls.
    Cheng S; Tylavsky F; Kröger H; Kärkkäinen M; Lyytikäinen A; Koistinen A; Mahonen A; Alen M; Halleen J; Väänänen K; Lamberg-Allardt C
    Am J Clin Nutr; 2003 Sep; 78(3):485-92. PubMed ID: 12936933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THE ASSOCIATIONS BETWEEN HYPOVITAMINOSIS D, HIGHER PTH LEVELS WITH BONE MINERAL DENSITIES, AND RISK OF THE 10-YEAR PROBABILITY OF MAJOR OSTEOPOROTIC FRACTURES IN CHINESE PATIENTS WITH T2DM.
    Wang XF; Yu JJ; Wang XJ; Jing YX; Sun LH; Tao B; Wang WQ; Ning G; Liu JM; Zhao HY
    Endocr Pract; 2018 Apr; 24(4):334-341. PubMed ID: 29658832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HR-pQCT detects alterations in bone microstructure in men with CKD stages 3 and 4, which are influenced by hormonal changes and body composition
.
    Paranhos-Neto FP; Lima GAC; Silva LC; Madeira M; Vieira Neto L; Mendonça LMC; Lima ICB; Delgado AG; Leite M; Gomes CP; F Farias ML
    Clin Nephrol; 2018 Jan; 89 (2018)(1):10-17. PubMed ID: 29189197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.
    Hughes-Austin JM; Katz R; Semba RD; Kritchevsky SB; Bauer DC; Sarnak MJ; Ginsberg C; Shlipak MG; Lima F; Malluche HH; Ix JH
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2903-11. PubMed ID: 32474604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.
    Raposo JF; Pires A; Yokota H; Ferreira HG
    Endocrine; 2012 Apr; 41(2):309-19. PubMed ID: 21874319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.